X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
animals (57) 57
index medicus (56) 56
glioblastoma (30) 30
mice (28) 28
oncology (25) 25
cancer (23) 23
rats (22) 22
neurosciences (21) 21
angiogenesis (19) 19
glioblastoma - pathology (19) 19
glioma (19) 19
expression (18) 18
tumors (18) 18
brain (16) 16
brain neoplasms - pathology (16) 16
female (16) 16
male (15) 15
clinical neurology (14) 14
gliomas (14) 14
in-vivo (14) 14
brain tumors (13) 13
mice, scid (13) 13
brain neoplasms - genetics (12) 12
brain neoplasms - metabolism (12) 12
cell line, tumor (12) 12
glioblastoma - metabolism (12) 12
bevacizumab (11) 11
biochemistry & molecular biology (11) 11
cells, cultured (11) 11
glioblastoma - genetics (11) 11
multidisciplinary sciences (11) 11
abstracts (10) 10
brain cancer (10) 10
cell biology (10) 10
genetic aspects (10) 10
hypoxia (10) 10
medical and health sciences (10) 10
medicin och hälsovetenskap (10) 10
metabolism (10) 10
mice, inbred nod (10) 10
stem cells (10) 10
xenograft model antitumor assays (10) 10
gene expression (9) 9
mass spectrometry (9) 9
research (9) 9
biology (8) 8
brain neoplasms - drug therapy (8) 8
cancer and oncology (8) 8
cancer och onkologi (8) 8
cell proliferation (8) 8
cells (8) 8
clinical medicine (8) 8
klinisk medicin (8) 8
mutation (8) 8
neoplasm transplantation (8) 8
therapy (8) 8
xenografts (8) 8
animal models (7) 7
disease models, animal (7) 7
endothelial growth-factor (7) 7
glioblastoma - drug therapy (7) 7
growth (7) 7
medical research (7) 7
medicine (7) 7
mouse model (7) 7
research article (7) 7
survival (7) 7
analysis (6) 6
biomarkers (6) 6
brain-tumors (6) 6
cell lines (6) 6
cell survival (6) 6
development and progression (6) 6
gene-expression (6) 6
genetics (6) 6
glioblastoma multiforme (6) 6
health aspects (6) 6
heterografts (6) 6
invasion (6) 6
magnetic resonance imaging (6) 6
pathology (6) 6
phase-ii trial (6) 6
phenotype (6) 6
physiological aspects (6) 6
rats, nude (6) 6
science (6) 6
signal transduction (6) 6
tumor microenvironment (6) 6
brain - pathology (5) 5
cell line (5) 5
central-nervous-system (5) 5
egfr (5) 5
epidermal growth factor (5) 5
gene expression regulation, neoplastic (5) 5
genomics (5) 5
genotype & phenotype (5) 5
glycolysis (5) 5
human glioblastoma (5) 5
identification (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cell Stem Cell, ISSN 1934-5909, 2011, Volume 8, Issue 2, pp. 136 - 147
The “Side Population” (SP) discrimination assay is a flow cytometry method used to detect stem cells based on the dye efflux properties of ABC transporters. We... 
ABCG2 EXPRESSION | RESISTANCE PROTEIN | DYE EFFLUX | BONE-MARROW | IN-VIVO | MOUSE MODEL | NEURAL STEM | BLOOD-BRAIN-BARRIER | DRUG EFFLUX TRANSPORTERS | P-GLYCOPROTEIN | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Neoplastic Stem Cells - cytology | Phenotype | Neoplastic Stem Cells - metabolism | Humans | Ploidies | Stem Cells - cytology | Stem Cells - metabolism
Journal Article
RNA, ISSN 1355-8382, 11/2014, Volume 20, Issue 11, pp. 1655 - 1665
Journal Article
by Waddell, Nicola and Pajic, Marina and Patch, Ann-Marie and Chang, David K and Kassahn, Karin S and Bailey, Peter and Johns, Amber L and Miller, David and Nones, Katia and Quek, Kelly and Quinn, Michael C. J and Robertson, Alan J and Fadlullah, Muhammad Z. H and Bruxner, Tim J. C and Christ, Angelika N and Harliwong, Ivon and Idrisoglu, Senel and Manning, Suzanne and Nourse, Craig and Nourbakhsh, Ehsan and Wani, Shivangi and Wilson, Peter J and Markham, Emma and Cloonan, Nicole and Anderson, Matthew J and Fink, J. Lynn and Holmes, Oliver and Kazakoff, Stephen H and Leonard, Conrad and Newell, Felicity and Poudel, Barsha and Song, Sarah and Taylor, Darrin and Waddell, Nick and Wood, Scott and Xu, Qinying and Wu, Jianmin and Pinese, Mark and Cowley, Mark J and Lee, Hong C and Jones, Marc D and Nagrial, Adnan M and Humphris, Jeremy and Chantrill, Lorraine A and Chin, Venessa and Steinmann, Angela M and Mawson, Amanda and Humphrey, Emily S and Colvin, Emily K and Chou, Angela and Scarlett, Christopher J and Pinho, Andreia V and Giry-Laterriere, Marc and Rooman, Ilse and Samra, Jaswinder S and Kench, James G and Pettitt, Jessica A and Merrett, Neil D and Toon, Christopher and Epari, Krishna and Nguyen, Nam Q and Barbour, Andrew and Zeps, Nikolajs and Jamieson, Nigel B and Graham, Janet S and Niclou, Simone P and Bjerkvig, Rolf and Grützmann, Robert and Aust, Daniela and Hruban, Ralph H and Maitra, Anirban and Iacobuzio-Donahue, Christine A and Wolfgang, Christopher L and Morgan, Richard A and Lawlor, Rita T and Corbo, Vincenzo and Bassi, Claudio and Falconi, Massimo and Zamboni, Giuseppe and Tortora, Giampaolo and Tempero, Margaret A and Gill, Anthony J and Eshleman, James R and Pilarsky, Christian and Scarpa, Aldo and Musgrove, Elizabeth A and Pearson, John V and Biankin, Andrew V and Grimmond, Sean M and Australian Pancreatic Canc Genome and Australian Pancreatic Cancer Genome Initiative
Nature, ISSN 0028-0836, 02/2015, Volume 518, Issue 7540, pp. 495 - 501
Journal Article
Nature Cell Biology, ISSN 1465-7392, 11/2015, Volume 17, Issue 12, pp. 1556 - 1568
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2011, Volume 108, Issue 9, pp. 3749 - 3754
Bevacizumab, an antibody against vascular endothelial growth factor (VEGF), is a promising, yet controversial, drug in human glioblastoma treatment (GBM). Its... 
Cellular metabolism | Glioma | Quantification | Perfusion | Glioblastoma | Blood vessels | Heterologous transplantation | Tumors | Cancer | Blood flow | Angiogenesis | Metabolism | TARGETED THERAPY | perfusion | angiogenesis | MULTIDISCIPLINARY SCIENCES | BEVACIZUMAB PLUS IRINOTECAN | BRAIN-TUMORS | ANTIANGIOGENIC THERAPY | PHASE-II TRIAL | STEM-LIKE CELLS | IN-VIVO | glioma | metabolism | RECURRENT MALIGNANT GLIOMAS | ENDOTHELIAL GROWTH-FACTOR | Glioblastoma - enzymology | Humans | Blood Volume - drug effects | Capillary Permeability - drug effects | Antibodies, Monoclonal - therapeutic use | Phosphatidylinositol 3-Kinases - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Rats, Nude | Wnt Proteins - metabolism | Bevacizumab | Neovascularization, Pathologic - pathology | Antibodies, Monoclonal, Humanized | Glioblastoma - ultrastructure | Cell Hypoxia - drug effects | Neoplasm Invasiveness | Antibodies, Monoclonal - pharmacology | Rats | Enzyme Activation - drug effects | Disease Progression | Xenograft Model Antitumor Assays | Magnetic Resonance Imaging | Animals | Contrast Media | Signal Transduction - drug effects | Neovascularization, Pathologic - drug therapy | Glioblastoma - pathology | Glioblastoma - blood supply | Vascular endothelial growth factor | Health aspects | Glioblastoma multiforme | Biological Sciences | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cancer and Oncology | Klinisk medicin | Cancer och onkologi
Journal Article
Neuro-Oncology, ISSN 1522-8517, 08/2012, Volume 14, Issue 8, pp. 979 - 993
Animal modeling for primary brain tumors has undergone constant development over the last 60 years, and significant improvements have been made recently with... 
animal models | brain tumor development | NEURAL PROGENITORS | NERVOUS-SYSTEM | SIDE POPULATION ASSAY | ATHYMIC MICE | MOUSE MODELS | CLINICAL NEUROLOGY | MOLECULAR ANALYSIS | ONCOLOGY | HUMAN-MALIGNANT GLIOMA | ANIMAL-MODELS | STEM-CELL | NUDE RAT | Animals | Humans | Glioblastoma | Brain Neoplasms | Disease Models, Animal | Reviews
Journal Article